Axon (NASDAQ: AXON) CAO earns 3,906 shares held to as late as 2030

Rhea-AI Filing Summary

AXON ENTERPRISE, INC. reported that Chief Accounting Officer Jennifer H. Mak acquired 3,906 shares of common stock through settlement of performance-based restricted stock units (XSUs). These XSUs were granted on December 22, 2023 under the 2024 eXponential Stock Plan, with performance for the fourth tranche certified as achieved on August 16, 2026. The tranche is scheduled to vest on December 1, 2026, subject to continued employment, and the delivered shares will be subject to a minimum holding period. Following this award, Mak directly holds 13,755.968 shares of Axon common stock.

Insider Trade Summary

Net Buyer: 3,906 shares

Net Buy 1 txn

Insider Mak Jennifer H

Role Chief Accounting Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	3,906	$0.00	$0.00

Holdings After Transaction: Common Stock — 13,755.968 shares (Direct)

Footnotes (1)

1. F1. The transaction consists of performance-based restricted stock units (collectively, "XSUs") granted on December 22, 2023 pursuant to the Axon Enterprise, Inc. 2024 eXponential Stock Plan, for which the performance conditions for the fourth tranche of XSUs (the "Tranche") were certified by the issuer's Compensation Committee of the Board of Directors on August 16, 2026 as having been met. The Tranche will vest on December 1, 2026, subject to continued employment through such date. Following the vesting, the shares deliverable for the Tranche are subject to a minimum holding period until the earlier of (i) December 31, 2030 and (ii) the date on which a subsequent tranche of XSUs vests, excluding shares withheld or sold to cover applicable taxes.

Key Figures

Shares acquired: 3,906 shares Post-transaction holdings: 13,755.968 shares Grant date of XSUs: December 22, 2023 +2 more

5 metrics

Shares acquired 3,906 shares Performance-based restricted stock units (fourth tranche of XSUs) credited on August 16, 2026

Post-transaction holdings 13,755.968 shares Direct ownership of Axon common stock after the reported acquisition

Grant date of XSUs December 22, 2023 Original grant date of performance-based XSUs under the 2024 eXponential Stock Plan

Vesting date of tranche December 1, 2026 Scheduled vesting date for the fourth tranche, subject to continued employment

Minimum holding period end December 31, 2030 Latest date through which shares from the tranche must be held, absent earlier subsequent tranche vesting

Key Terms

performance-based restricted stock units, 2024 eXponential Stock Plan, Compensation Committee, minimum holding period

4 terms

performance-based restricted stock units financial

"The transaction consists of performance-based restricted stock units (collectively, "XSUs") granted"

Performance-based restricted stock units are a type of employee equity award that converts into company shares only if predefined financial or operational targets are met over a set period. Think of it like a bonus check that becomes stock only when specific goals are hit; it ties pay to results, aligning managers’ incentives with shareholders. Investors care because these awards affect future share count, executive incentives, and signal how management’s success will be measured and rewarded.

2024 eXponential Stock Plan financial

"granted on December 22, 2023 pursuant to the Axon Enterprise, Inc. 2024 eXponential Stock Plan"

Compensation Committee financial

"performance conditions ... were certified by the issuer's Compensation Committee of the Board"

A compensation committee is a group within a company's leadership responsible for setting and reviewing how much top executives and employees are paid, including salaries, bonuses, and benefits. It matters to investors because fair and effective pay decisions can influence a company's performance, leadership motivation, and overall governance, helping ensure that the company’s management is aligned with shareholders’ interests.

minimum holding period financial

"the shares deliverable for the Tranche are subject to a minimum holding period until"

FAQ

What insider transaction did AXON (AXON) disclose for Jennifer H. Mak?

AXON disclosed that Chief Accounting Officer Jennifer H. Mak acquired 3,906 shares of common stock through performance-based restricted stock units. These units relate to a 2023 grant under the 2024 eXponential Stock Plan, with performance for the fourth tranche certified on August 16, 2026.

How many AXON (AXON) shares does Jennifer H. Mak hold after this Form 4 transaction?

After the reported transaction, Jennifer H. Mak directly holds 13,755.968 AXON common shares. This total reflects the addition of 3,906 shares from the performance-based restricted stock units that were certified as earned for the fourth tranche on August 16, 2026.

What are the key dates for the AXON (AXON) XSUs granted to Jennifer H. Mak?

The XSUs were granted on December 22, 2023, performance for the fourth tranche was certified on August 16, 2026, and the tranche is scheduled to vest on December 1, 2026, subject to Ms. Mak’s continued employment through that vesting date.

What conditions apply to the vesting of Jennifer H. Mak’s AXON (AXON) XSU tranche?

The fourth tranche of XSUs will vest on December 1, 2026, provided Jennifer H. Mak remains employed through that date. After vesting, the delivered shares are also subject to a minimum holding period defined in the plan and footnote description.

Is there a holding period on the AXON (AXON) shares from Jennifer H. Mak’s XSUs?

Yes. After vesting, the shares deliverable for the tranche are subject to a minimum holding period until the earlier of December 31, 2030 or the vesting date of a subsequent XSU tranche, excluding shares withheld or sold for taxes.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/17/2026 - 05:22 PM Accepted by SEC EDGAR 08/17/2026 - 05:21 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mak Jennifer H

(Last) (First) (Middle)

17800 N 85TH ST

(Street)

SCOTTSDALE ARIZONA 85255

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AXON ENTERPRISE, INC. [ AXON ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Accounting Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/16/2026		A(1)		3,906	A	$0	13,755.968	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The transaction consists of performance-based restricted stock units (collectively, "XSUs") granted on December 22, 2023 pursuant to the Axon Enterprise, Inc. 2024 eXponential Stock Plan, for which the performance conditions for the fourth tranche of XSUs (the "Tranche") were certified by the issuer's Compensation Committee of the Board of Directors on August 16, 2026 as having been met. The Tranche will vest on December 1, 2026, subject to continued employment through such date. Following the vesting, the shares deliverable for the Tranche are subject to a minimum holding period until the earlier of (i) December 31, 2030 and (ii) the date on which a subsequent tranche of XSUs vests, excluding shares withheld or sold to cover applicable taxes.

Remarks:

	/s/ Jennifer H. Mak by Isaiah Fields, Attorney-in-Fact	08/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)